SEC Form 4 · accession 0000899866-17-000144
ALEXION PHARMACEUTICALS, INC. · ALXN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ludwig Hantson
Officer — CEO · Director
Period of report
Jun 14, 2017
Accepted (ET)
Jun 19, 2017 · 5:21 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000899866
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $.0001 per share | Jun 14, 2017 | P | 10,000 | $116.72 | A | 38,725 | D |
Table II — derivative securities
No Table II lines on this filing.